Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?
Identifieur interne : 000230 ( Main/Exploration ); précédent : 000229; suivant : 000231Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?
Auteurs : Ömer Kutlu [Turquie] ; Ahmet Metin [Turquie]Source :
- Dermatologic therapy [ 1529-8019 ] ; 2020.
Abstract
Recent studies have focused on the comorbid conditions of the COVID-19. According to the current studies, numerous diseases including lung disease, cardiovascular disease and immunosuppression appear to be at higher risk for severe forms of the COVID-19. To date, there are no data in the literature on the comorbid dermatologic diseases and COVID-19. We tried to analyze the previous dermatological comorbidity of 93 patients with COVID-19 (51 males, 42 females) who presented to the dermatology outpatient clinics for the last 3 years. The most common dermatologic diseases in patients with COVID-19 who have dermatologic diseases for the last 3 years were superficial fungal infections (24, 25.8%), seborrheic dermatitis (11, 11.8%), actinic keratosis (10, 10.8%), psoriasis (6, 6.5%), and eczema (6, 6.5%), respectively. In addition, the number of COVID-19 patients who presented to dermatology in the last 3 months was 17 (11 men, 6 women). The median age of these patients was 58 (minimum 18, maximum 80) years, and the most common dermatologic diseases before diagnosed COVID-19 were superficial fungal infections (5, 25%), psoriasis (4, 20%), and viral skin diseases (3, 15%). The possible similarity between cutaneous and mucosal immunity and immunosuppression suggests that patients with some dermatologic diseases especially superficial fungal infections and psoriasis may be more vulnerable to the COVID-19.
DOI: 10.1111/dth.13509
PubMed: 32367558
PubMed Central: PMC7261987
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?</title><author><name sortKey="Kutlu, Omer" sort="Kutlu, Omer" uniqKey="Kutlu O" first="Ömer" last="Kutlu">Ömer Kutlu</name><affiliation wicri:level="1"><nlm:affiliation>Uşak University, Department of Dermatology and Venereology, School of Medicine, Uşak, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Uşak University, Department of Dermatology and Venereology, School of Medicine, Uşak</wicri:regionArea><wicri:noRegion>Uşak</wicri:noRegion></affiliation></author><author><name sortKey="Metin, Ahmet" sort="Metin, Ahmet" uniqKey="Metin A" first="Ahmet" last="Metin">Ahmet Metin</name><affiliation wicri:level="1"><nlm:affiliation>Uşak University, Department of Dermatology and Venereology, School of Medicine, Uşak, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Uşak University, Department of Dermatology and Venereology, School of Medicine, Uşak</wicri:regionArea><wicri:noRegion>Uşak</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32367558</idno><idno type="pmid">32367558</idno><idno type="doi">10.1111/dth.13509</idno><idno type="pmc">PMC7261987</idno><idno type="wicri:Area/Main/Corpus">000315</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000315</idno><idno type="wicri:Area/Main/Curation">000315</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000315</idno><idno type="wicri:Area/Main/Exploration">000315</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?</title><author><name sortKey="Kutlu, Omer" sort="Kutlu, Omer" uniqKey="Kutlu O" first="Ömer" last="Kutlu">Ömer Kutlu</name><affiliation wicri:level="1"><nlm:affiliation>Uşak University, Department of Dermatology and Venereology, School of Medicine, Uşak, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Uşak University, Department of Dermatology and Venereology, School of Medicine, Uşak</wicri:regionArea><wicri:noRegion>Uşak</wicri:noRegion></affiliation></author><author><name sortKey="Metin, Ahmet" sort="Metin, Ahmet" uniqKey="Metin A" first="Ahmet" last="Metin">Ahmet Metin</name><affiliation wicri:level="1"><nlm:affiliation>Uşak University, Department of Dermatology and Venereology, School of Medicine, Uşak, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Uşak University, Department of Dermatology and Venereology, School of Medicine, Uşak</wicri:regionArea><wicri:noRegion>Uşak</wicri:noRegion></affiliation></author></analytic><series><title level="j">Dermatologic therapy</title><idno type="eISSN">1529-8019</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Recent studies have focused on the comorbid conditions of the COVID-19. According to the current studies, numerous diseases including lung disease, cardiovascular disease and immunosuppression appear to be at higher risk for severe forms of the COVID-19. To date, there are no data in the literature on the comorbid dermatologic diseases and COVID-19. We tried to analyze the previous dermatological comorbidity of 93 patients with COVID-19 (51 males, 42 females) who presented to the dermatology outpatient clinics for the last 3 years. The most common dermatologic diseases in patients with COVID-19 who have dermatologic diseases for the last 3 years were superficial fungal infections (24, 25.8%), seborrheic dermatitis (11, 11.8%), actinic keratosis (10, 10.8%), psoriasis (6, 6.5%), and eczema (6, 6.5%), respectively. In addition, the number of COVID-19 patients who presented to dermatology in the last 3 months was 17 (11 men, 6 women). The median age of these patients was 58 (minimum 18, maximum 80) years, and the most common dermatologic diseases before diagnosed COVID-19 were superficial fungal infections (5, 25%), psoriasis (4, 20%), and viral skin diseases (3, 15%). The possible similarity between cutaneous and mucosal immunity and immunosuppression suggests that patients with some dermatologic diseases especially superficial fungal infections and psoriasis may be more vulnerable to the COVID-19.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32367558</PMID><DateRevised><Year>2020</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-8019</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>May</Month><Day>05</Day></PubDate></JournalIssue><Title>Dermatologic therapy</Title><ISOAbbreviation>Dermatol Ther</ISOAbbreviation></Journal><ArticleTitle>Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?</ArticleTitle><Pagination><MedlinePgn>e13509</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/dth.13509</ELocationID><Abstract><AbstractText>Recent studies have focused on the comorbid conditions of the COVID-19. According to the current studies, numerous diseases including lung disease, cardiovascular disease and immunosuppression appear to be at higher risk for severe forms of the COVID-19. To date, there are no data in the literature on the comorbid dermatologic diseases and COVID-19. We tried to analyze the previous dermatological comorbidity of 93 patients with COVID-19 (51 males, 42 females) who presented to the dermatology outpatient clinics for the last 3 years. The most common dermatologic diseases in patients with COVID-19 who have dermatologic diseases for the last 3 years were superficial fungal infections (24, 25.8%), seborrheic dermatitis (11, 11.8%), actinic keratosis (10, 10.8%), psoriasis (6, 6.5%), and eczema (6, 6.5%), respectively. In addition, the number of COVID-19 patients who presented to dermatology in the last 3 months was 17 (11 men, 6 women). The median age of these patients was 58 (minimum 18, maximum 80) years, and the most common dermatologic diseases before diagnosed COVID-19 were superficial fungal infections (5, 25%), psoriasis (4, 20%), and viral skin diseases (3, 15%). The possible similarity between cutaneous and mucosal immunity and immunosuppression suggests that patients with some dermatologic diseases especially superficial fungal infections and psoriasis may be more vulnerable to the COVID-19.</AbstractText><CopyrightInformation>© 2020 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kutlu</LastName><ForeName>Ömer</ForeName><Initials>Ö</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-9665-015X</Identifier><AffiliationInfo><Affiliation>Uşak University, Department of Dermatology and Venereology, School of Medicine, Uşak, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metin</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-6512-4990</Identifier><AffiliationInfo><Affiliation>Uşak University, Department of Dermatology and Venereology, School of Medicine, Uşak, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dermatol Ther</MedlineTA><NlmUniqueID>9700070</NlmUniqueID><ISSNLinking>1396-0296</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">dermatology</Keyword><Keyword MajorTopicYN="N">immunosuppression</Keyword><Keyword MajorTopicYN="N">psoriasis</Keyword><Keyword MajorTopicYN="N">superficial fungal infections</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>04</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32367558</ArticleId><ArticleId IdType="doi">10.1111/dth.13509</ArticleId><ArticleId IdType="pmc">PMC7261987</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Guo YR, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Mil Med Res. 2020;7(1):1-10.</Citation></Reference><Reference><Citation>https://covid19.saglik.gov.tr/</Citation></Reference><Reference><Citation>Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?Lancet Respir Med. 2020;8(4):e21.</Citation></Reference><Reference><Citation>Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan. China Allergy. 2020. https://doi.org/10.1111/all.14238.</Citation></Reference><Reference><Citation>Conforti C, Cannavò SP, Jafferany M, et al. Coronavirus disease 2019 (COVID-19): facts and controversies. Dermatol Ther. 2020. https://doi.org/10.1111/dth.13366.</Citation></Reference><Reference><Citation>Kutlu Ö, Metin A. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: will cases of psoriasis increase after COVID-19 pandemic?Dermatol Ther. 2020. https://doi.org/10.1111/dth.13383.</Citation></Reference><Reference><Citation>Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I. COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action. Dermatol Ther. 2020. https://doi.org/10.1111/dth.13298.</Citation></Reference><Reference><Citation>Abdelmaksoud A, Goldust M, Vestita M. Comment on “COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action”. Dermatol Ther. 2020. https://doi.org/10.1111/dth.13360.</Citation></Reference><Reference><Citation>Kutlu Ö, Doğan Z, Ekşioğlu H, Kekilli M. Relationship between helicobacter pylori infection and pityriasis versicolor: can helicobacter pylori infection be a new etiologic factor for pityriasis versicolor?Turk J Med Sci. 2020. https://doi.org/10.3906/sag-1910-48.</Citation></Reference><Reference><Citation>Hovav AH. Mucosal and skin langerhans cells-nurture calls. Trends Immunol. 2018;39(10):788-800.</Citation></Reference><Reference><Citation>Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of SARS-CoV-2 infection a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020;9(1):727-732.</Citation></Reference><Reference><Citation>Prasad A. Local ımmunity concept in the context of the novel corona viral ınfection: a consideration. Asian J Immunol. 2020;3(2):16-25.</Citation></Reference><Reference><Citation>Belyakov IM, Hel Z, Kelsall B, et al. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med. 2001;7(12):1320-1326.</Citation></Reference><Reference><Citation>Heinen MP, Cambier L, Antoine N, et al. Th1 and Th17 immune responses act complementarily to optimally control superficial dermatophytosis. J Invest Dermatol. 2019;139(3):626-637.</Citation></Reference><Reference><Citation>Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin d supplementation could reduce risk of ınfluenza and COVID-19 ınfections and deaths. Nutrients. 2020;12(4):988.</Citation></Reference><Reference><Citation>Cakman I, Kırchener H, Rınk L. Zinc supplementation reconstitutes the production of interferon-α by leukocytes from elderly persons. J Interferon Cytokine Res. 1997;17(8):469-472.</Citation></Reference><Reference><Citation>Razzaque M. COVID-19 pandemic: can maintaining optimal zinc balance enhance host resistance?Preprints. 2020. https://doi.org/10.20944/preprints202004.0006.v1.</Citation></Reference><Reference><Citation>Wikramanayake TC, Borda LJ, Miteva M, Paus R. Seborrheic dermatitis-looking beyond malassezia. Exp Dermatol. 2019;28(9):991-1001.</Citation></Reference><Reference><Citation>Aktaş Karabay E, Aksu ÇA. Serum zinc levels in seborrheic dermatitis: a case-control study. Turk J Med Sci. 2019;49(5):1503-1508.</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Turquie</li></country></list><tree><country name="Turquie"><noRegion><name sortKey="Kutlu, Omer" sort="Kutlu, Omer" uniqKey="Kutlu O" first="Ömer" last="Kutlu">Ömer Kutlu</name></noRegion><name sortKey="Metin, Ahmet" sort="Metin, Ahmet" uniqKey="Metin A" first="Ahmet" last="Metin">Ahmet Metin</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000230 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000230 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CardioCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32367558
|texte= Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32367558" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CardioCovidV1
| This area was generated with Dilib version V0.6.35. |  |